BUBS AUSTRALIA LIMITED (BUB)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BUB

BUB - BUBS AUSTRALIA LIMITED

FNArena Sector : Dairy
Year End: June
GICS Industry Group : Food, Beverage & Tobacco
Debt/EBITDA: 0.27
Index:

Bubs is an Australian producer of infant formula and organic baby food and cereals. First listed in 1993, the company relisted in 2017 under the name Bubs Australia.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.145

17 Nov
2025

0.000

OPEN

$0.15

0.000

HIGH

$0.15

215,633

LOW

$0.15

TARGET
$0.185 27.6% upside
OTHER COMPANIES IN THE SAME SECTOR
A2M . BGA . NUC . NUC . SM1 . TFL .
FNARENA'S MARKET CONSENSUS FORECASTS
BUB: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 0.6 0.4 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A - 40.9% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 39.5 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 0.00

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx0.6
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx102.5 M
Book Value Per Share xxxxxxxxxxxxxxx4.8
Net Operating Cash Flow xxxxxxxxxxxxxxx6.1 M
Net Profit Margin xxxxxxxxxxxxxxx5.41 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx13.97 %
Return on Invested Capital xxxxxxxxxxxxxxx13.75 %
Return on Assets xxxxxxxxxxxxxxx8.95 %
Return on Equity xxxxxxxxxxxxxxx13.97 %
Return on Total Capital xxxxxxxxxxxxxxx5.84 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx6.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx0 M
Total Debt xxxxxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxxxxx91 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx17 M
Price To Book Value xxxxxxxxxxxxxxx3.78

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx0.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.12 %
Cost of Goods Sold xxxxxxxxxxxxxxx54 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx46 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Shaw and Partners

03/11/2025

1

Buy

$0.20

37.93%

Bubs Australia's 1Q26 net revenue rose 30% y/y to $25.6m, outperforming Shaw and Partners' 1H26 growth forecast of 21.4% in terms of run rate. The company achieved this despite issues with inventory availability.

EBITDA came in at $0.5m, rebounding from a -$4.3m loss in 1Q25, and tracking close to Shaw’s 1H26 forecast of $0.6m. Operating cash outflow was $4.4m due to inventory rebuild and is expected to remain negative in 2Q but turn positive in 3Q-4Q FY26.

The broker notes US sales were strong at 49% y/y growth, offsetting weaker China, Australia, and ROW due to stock constraints.

FDA approval to sell infant formula products permanently in the US is expected by the end of 2025.

No change to forecasts. Buy rating and target unchanged at 20c.

FORECAST
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.20 cents.

Bell Potter

xx/xx/xxxx

3

xxxxxxxxxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

BUB STOCK CHART

FNArena News on BUB

1
Weekly Ratings, Targets, Forecast Changes – 19-09-25

Sep 22 2025 - Weekly Reports
2
FNArena Corporate Results Monitor – 01-09-2025

Sep 01 2025 - Australia
3
Rudi’s View: BlueScope Steel, IGO, GrainCorp, Pilbara Minerals, Santos & More

Aug 14 2025 - Rudi's View
4
Rudi’s View: AI Updates, Hot Favourites & First August Results

Aug 07 2025 - Rudi's View
5
Rudi’s View: Bega Cheese, Cettire, Harvey Norman, Sigma, SiteMinder & More

Jul 24 2025 - Rudi's View

Latest Dairy News

1
Bega Cheese Preparing For Accelerated Growth

Sep 22 2025 - Small Caps
2
Growing Confidence in Bega Cheese

Jun 17 2025 - Small Caps
3
A2 Milks It

Feb 18 2025 - Australia
4
a2 Milk Starts Paying Dividends

Nov 27 2024 - Australia
5
Buy Call For a2 Milk

Mar 21 2024 - Technicals
6
A2 Milking It

Feb 21 2024 - Australia
7
Treasure Chest: Bega Cheese

Oct 18 2022 - Treasure Chest
8
a2 Milk Pumps Up Growth Expectations

Oct 29 2021 - Australia
9
Bega Cheese: Melting Up?

Jun 01 2021 - Technicals
10
Synlait Milk Eyes Recovery, But Risks Remain

May 26 2021 - Australia